SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-001331
Filing Date
2019-01-30
Accepted
2019-01-30 06:02:56
Documents
3
Period of Report
2019-01-30

Document Format Files

Seq Description Document Type Size
1 6-K asln-6k_20190130.htm 6-K 20269
2 EX-99.1 asln-ex991_6.htm EX-99.1 14779
3 GRAPHIC goixaw5kw4ot000001.jpg GRAPHIC 12654
  Complete submission text file 0001564590-19-001331.txt   53663
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 19550249
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1